Canadian pharmaceutical company Knight Therapeutics Inc. and its Brazilian peer Eurofarma Laboratórios SA expressed interest in buying a controlling stake in Biotoscana Investments SA, Reuters reported, citing a source with knowledge of the matter.
Biotoscana's majority shareholders Advent International Corp. and Essex Woodlands Management Inc., or EW Healthcare Partners, are looking to exit their stakes in the Latin America-focused biopharmaceutical company, the news outlet noted, citing an earlier report from financial blog Brazil Journal.
Advent, EW Healthcare, Eurofarma, Knight and Biotoscana did not immediately respond to requests for comment, according to Reuters.
